40th Annual J.P. Morgan HealthCare Conference — Synthetic Biology Panel

— Tycho Peterson, Managing Director, Life Science Tools & Diagnostics, J.P. Morgan
— Ipsita Smolinski, Managing Director, Capitol Street

Abstract: Join the panel to discuss the genetic technology known as synthetic biology. Two industry heavyweights — Ginkgo & Inscripta — will describe genomic engineering & organism technologies. The White House will weigh in on how it evaluates technologies and partnerships to further US science and technology priorities. One key trade association will discuss the impact synthetic biology has on non-health applications, fragrances and other flavors.